n6 has expanded access to its AutoNorm™ adaptive amplification technology with the launch of the icon16™, a 16-well system designed for laboratories running lower-throughput next-generation sequencing (NGS) workflows without compromising data quality. With icon16, this capability is now accessible to labs processing smaller batch sizes, including targeted sequencing, rare variant detection, and low-input or high-value clinical samples. PCR remains a critical control point in NGS library preparation. Traditional fixed-cycle approaches assume uniform amplification efficiency across samples—an assumption that often introduces bias, dropout, or over-amplification artifacts. The icon16 replaces this model with: The result is a plate of libraries that are inherently normalized during amplification, removing the need for manual quantification and reducing downstream cleanup steps prior to pooling. While 96-well systems are optimized for scale, many laboratories operate in workflows where sample volume is limited but data quality requirements remain high. The icon16 is purpose-built for these environments, including: In these use cases, failed libraries are not easily repeated, making amplification precision essential rather than optional. The icon16 is designed for seamless integration into existing laboratory workflows: For labs seeking to improve reproducibility without revalidating entire workflows, this drop-in compatibility is a key advantage. AutoNorm technology has already been adopted by genomics core facilities and research institutions globally. With the introduction of icon16, n6 is targeting a broader segment of the market—labs that require the same level of precision but operate at smaller scale. By aligning amplification endpoints to individual sample kinetics rather than fixed cycle counts, the system standardizes one of the most variable steps in NGS library preparation.
Originally introduced with the icon96™, AutoNorm technology addresses a longstanding limitation in library preparation: fixed-cycle PCR amplification. By monitoring fluorescence in real time at the individual well level, the system stops amplification precisely when each sample reaches its optimal endpoint—eliminating overcycling, reducing variability, and removing the need for post-PCR normalization.Eliminating Variability at the PCR Stage
Designed for Low-Throughput, High-Value Samples
Workflow Compatibility Without Method Changes
Extending AutoNorm Beyond High-Throughput Labs
Learn more